 |
인쇄하기
취소
|
KORUS-FTA may be efficient tool to defy measure designed to reduce insurance expenditures
Published: 2011-11-30 07:00:00
Updated: 2011-11-30 07:00:00
The country’s pharmaceutical companies face tough times ahead with the new Korea-U.S. Free Trade Agreement that will put a brake on the generic-focused Korean industry.
As for the pharmaceuticals industry, the introduction of the patent linkage system is expected to result in a drop of as much as 120 billion won in drug production each year over a period of 10 years.
Under the patent link...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.